PH receives 700K AstraZeneca COVID-19 vaccines donated by Australia | Inquirer News

PH receives 700K AstraZeneca COVID-19 vaccines donated by Australia

By: - Reporter / @DYGalvezINQ
/ 10:06 AM November 24, 2021

MANILA, Philippines — Some 700,000 doses of AstraZeneca COVID-19 vaccine donated by Australia were delivered to the Philippines on Wednesday morning.

The vaccine doses arrived via plane which landed at the Ninoy Aquino International Airport (Naia) Terminal 3 at around 9:45 a.m, according to the National Task Force against COVID-19.

Article continues after this advertisement

The delivery of the doses came days after the government started administering COVID-19 boosters to senior citizens and persons with comorbidities who received their vaccine doses at least six months ago.

FEATURED STORIES

The government first administered booster shots to health workers.

Approved booster shots for health workers are single doses of Pfizer, Sinovac, and AstraZeneca vaccines and half the regular dose of a Moderna vaccine.

Article continues after this advertisement

So far, over 33.8 million Filipinos have completed the necessary doses of COVID-19, making them fully vaccinated against the illness, while 42.6 million have received at least their first dose.

The government is set to hold a three-day national vaccination drive on Nov. 29 to Dec. 1 with an aim to inoculate 15 million Filipinos.

EDV
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: AstraZeneca, Australia

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.